menu
    • menu

    Company profile for Catabasis Pharmaceuticals

    NEW Drugs in Dev: 8
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    In 2008, we recognized that traditional approaches to drug discovery and development may not address the multiple underlying defects causing a disease, and founded Catabasis Pharmaceuticals. We set foot on a path forward leveraging a technology we now call our SMART (Safely Metabolized And Rationally Targeted) Linker drug discovery platform. With this platform, we have engineered molecules that simultaneously modulate multiple...
    In 2008, we recognized that traditional approaches to drug discovery and development may not address the multiple underlying defects causing a disease, and founded Catabasis Pharmaceuticals. We set foot on a path forward leveraging a technology we now call our SMART (Safely Metabolized And Rationally Targeted) Linker drug discovery platform. With this platform, we have engineered molecules that simultaneously modulate multiple biological targets within one or more related disease pathways – thus allowing bioactives to reach their targets more efficiently and to have greater efficacy.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Catabasis PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    One Kendall Square, Bldg. 1400E, Suite B14202, Cambridge, MA 02139
    Telephone
    Telephone
    617-349-1971
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.catabasis.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/catabasis-pharmaceuticals-inc-
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/catabasispharma?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BioProcess International US West

    Not Confirmed

    envelop Contact Supplier

    BioProcess International US West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Catabasis rebrands post Duchenne disaster; Huadong joins Insilico in oncology
    Catabasis rebrands post Duchenne disaster; Huadong joins Insilico in oncology

    08 Sep 2021

    // Paul Schloesser\nMax Gelman ENDPTS

    https://endpts.com/catabasis-rebrands-as-astria-huadong-and-insilico-start-oncology-co-development/

    Paul Schloesser\nMax Gelman ENDPTS
    08 Sep 2021
    Share Share
    Catabasis Pharmaceuticals Announces New Company Name, Astria Therapeutics
    Catabasis Pharmaceuticals Announces New Company Name, Astria Therapeutics

    08 Sep 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210908005242/en

    BUSINESSWIRE
    08 Sep 2021
    Share Share
    Catabasis Pharmaceuticals Reports Second Quarter 2021 Financial Results
    Catabasis Pharmaceuticals Reports Second Quarter 2021 Financial Results

    09 Aug 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210809005642/en

    BUSINESSWIRE
    09 Aug 2021
    Share Share
    Catabasis Pharmaceuticals to Present at 2021 Wedbush PacGrow
    Catabasis Pharmaceuticals to Present at 2021 Wedbush PacGrow

    04 Aug 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210804005076/en

    BUSINESSWIRE
    04 Aug 2021
    Share Share
    Catabasis Pharmaceuticals To Present At Ladenburg Thalmann
    Catabasis Pharmaceuticals To Present At Ladenburg Thalmann

    07 Jul 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210707005084/en

    BUSINESSWIRE
    07 Jul 2021
    Share Share
    Catabasis Pharmaceuticals Reports First Quarter 2021 Financial Results
    Catabasis Pharmaceuticals Reports First Quarter 2021 Financial Results

    13 May 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210513005289/en/%C2%A0Catabasis-Pharmaceuticals-Reports-First-Quarter-2021-Financial-Results-and-Provides-a-Corporate-Update

    BUSINESSWIRE
    13 May 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search